Finance

Lists
CLNN:NASDAQ
Clene Inc
$3.96
-0.88%
(-0.035) 1D
Nov 13, 11:40:14 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLNN...
Open
$4.03
High
$4.43
Low
$3.90
Mkt. cap
57.10M
Avg. vol.
97.44K
Volume
7.45K
52-wk high
$10.84
52-wk low
$3.02
EPS
-$2.33
Beta
1.04
Shares outstanding
14.40M
No. of employees
78
Open
$4.03
High
$4.43
Low
$3.90
Mkt. cap
57.10M
Avg. vol.
97.44K
Volume
7.45K
52-wk high
$10.84
52-wk low
$3.02
EPS
-$2.33
Beta
1.04
Shares outstanding
14.40M
No. of employees
78
News stories
From web sources and news partners
About Clene Inc
CEO-
Employees78
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorHealth Care
IndustryBiotechnology
Websiteclene.com
Analyst ratings
Based on 4 analysts giving stock ratings to CLNN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CLNN in the last 3 months.
Highest
Current $3.96
$31.00 (+681.84%)
Average
$27.75 (+599.87%)
Lowest
$20.00 (+404.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Walsh
JonesTrading
Buy
Reiterated
$30.00
+656.6%
11/12/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$20.00
+404.4%
11/04/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$31.00
+681.8%
11/04/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$30.00
+656.6%
08/17/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$50.00
+1,161%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
77.00K
15.00K
90.00K
56.00K
Cost of goods sold
23.00K
-
36.00K
16.00K
Cost of revenue
23.00K
-
36.00K
16.00K
Research and development expenses
5.50M
329.00K
3.47M
4.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.05M
1.75M
1.93M
1.94M
Operating expense
7.55M
2.08M
5.40M
6.39M
Total operating expenses
7.57M
2.08M
5.44M
6.40M
Operating income
-7.50M
-2.06M
-5.35M
-6.35M
Other non operating income
-1.02M
-5.29M
-7.44M
10.88M
EBT including unusual items
-9.23M
-8.09M
-13.42M
3.92M
EBT excluding unusual items
-9.23M
-8.09M
-13.42M
3.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.23M
-8.09M
-13.42M
3.92M
Net profit margin
-11,981.82%
-53,940.00%
-14,915.56%
6,991.07%
Earnings per share
-0.78
-0.24
-0.48
-0.53
Interest and investment income
40.00K
47.00K
55.00K
50.00K
Interest expense
-746.00K
-791.00K
-695.00K
-665.00K
Net interest expenses
-706.00K
-744.00K
-640.00K
-615.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.14M
-1.71M
-4.99M
-6.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps